Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials.
Langley, R G, A B Kimball, H Nak, W Xu, B Pangallo, O O Osuntokun, N Agada, and K Reich. 2019. “Long-Term Safety Profile of Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis from 11 Clinical Trials.”. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (2): 333-39.